6 days ago ... METCALF v. ASTRAZENECA PHARMACEUTICALS LP et al (2:18-cv-09218), New Jersey District Court, Filed: 05/14/2018 - PacerMonitor ...
6 days ago ... WILLIS v. ASTRAZENECA PHARMACEUTICALS LP et al (2:18-cv-09220), New Jersey District Court, Filed: 05/14/2018 - PacerMonitor Mobile ...
Her ADA retaliation claim and wrongful discharge cause of action under Puerto Rico law failed as well (Delgado-Echevarria v. Astrazeneca Pharmaceutical, LP ...
NICO ELECTRICAL CONTRACTOR, INC. et al v. CITY OF ... SUPERIOR COURT OF NEW JERSEY et al ... LIVINGSTON v. ..... ASTRAZENECA AB et al v. .... NOVARTIS PHARMACEUTICALS CORPORATION .... CUBESMART L.P. et al
Feb 3, 2017 ... A Delaware federal judge ruled Thursday that AstraZeneca's ... the entire record in this case, the substantial evidence in the record, the ... Kassandra M. Officer, John D. Livingstone, M. David Weingarten and ... The case is AstraZeneca AB v. Aurobindo Pharma Ltd. et al., case number 1:14-cv-00664, in the ...
Jan 6, 2015 ... We used information on all people living with type 1 diabetes at any ..... from sanofi-aventis and Novartis Pharmaceuticals; costs for advisory ... grants from Boehringer Ingelheim; grants from AstraZeneca LP. ... Livingstone SJ, Looker HC , Hothersall EJ, et al. ... de Ferranti SD, de Boer IH, Fonseca V, et al.
Dec 7, 2013 ... All patients gave written informed consent before study entry, and the study protocol ..... This study was designed and funded by AstraZeneca Pharmaceuticals, Macclesfield, ... Howell A, Robertson JFR, Quaresma Albano J, et al. ..... Tirumali NR, Lew DL, Hayes DF, Gralow JR, Livingston RB, Hortobagyi GN.
Aug 31, 2016 ... change was +0.5 kg with IDegLira vs –1.0 kg with placebo [estimated treatment difference 1.48 kg (95% CI 0.90; 2.06); .... IDegLira in combination with sulphonylureas H. W. Rodbard et al. ... Ltd, Livingston, UK) performed laboratory analyses. ..... from AstraZeneca Pharmaceuticals LP, Biodel, Inc., Boeh-.
Astrazeneca UK Limited, IPR Pharmaceuticals Inc., and Shionogi Seiyaku ... DC, Mary K. Ferguson, of Cambridge, MA, John D. Livingstone, of Atlanta, GA, Mary ... See Peter H. Jones et al., Comparison of the Efficacy and Safety of ...... and in AstraZeneca Pharms. LP v. Aurobindo Pharma Ltd., 2009 WL 483131, at *3 (D. Del.